Protara Therapeutics, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position
Protara Therapeutics, Inc. (TARA) had Debt Securities, Available-for-sale, Unrealized Loss Position of $126.17 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-11
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $126.17M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $127.77M.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $53.86M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $25.53M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position |
|---|---|
| 2026-06-30 | $126.17M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $127.77M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $53.86M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $25.53M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $56.57M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $11.70M 10-Q · filed 2025-05-08 |
| 2023-09-30 | $165.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $336.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $474.00K 10-Q · filed 2023-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |